HudsonAlpha Discovery brings together advanced technologies, workflows optimized for quality and reproducibility, and an innovative, service-oriented scientific team to deliver reliable scientific insight delivered rapidly and at scale.
A world-class genomic services lab with industrial-scale capabilities
Whole Genome Sequencing
Scalable whole genome sequencing services with the coverage and quality to meet your project needs.
- Illumina, PacBio, and Oxford Nanopore platforms
- 30x, 60x, 90x, custom coverage options
- Matched DNA- and RNA-Seq from the same tissue
Targeted & Exome Sequencing
Multiple options for coverage, targeted sequencing panels, and capture platforms enable basic, translational, and clinical studies.
- IDT, Twist, Agilent capture platforms
- 50x, 100x, 300x, and custom coverage
- Illumina TruSight panels
Proprietary isolation protocols deliver high quality RNA even from difficult samples.
- Multiple RNA types, including mRNA, long non-coding RNA, miRNA, regulatory RNAs,exosomal RNA
- Robust RNA isolation from FFPE tissue
- Multiple RNA amplification and library construction methods from both low and high quality RNA
Single Cell Sequencing
Improve the resolution of your genomic data with single cell sequencing
- 10x Genomics technologies
- RNA-Seq, TCR-Seq, BCR-Seq, CITE-Seq, and ATAC-Seq
- 10x Genomics Cell Ranger Analysis
- Qualitative and quantitative analyses
Advance insight into epigenetic regulation of gene expression
- Illumina’s Infinium MethylationEPIC BeadChip (850K sites) technology
- ATAC-Seq with 10x Genomics technology
- Next generation sequencing (NGS) of bisulfite-treated libraries
Explore the microbiome with a range of metagenomic sequencing services.
- Nucleic acid extraction from environmental and clinical samples
- Whole genome shotgun metagenomics
- Metatranscriptomic sequencing
- 16S rRNA sequencing
Power your precision biomarker programs with pathology guided tissue biomarker services.
Make strategic decisions with confidence. Our experts help you identify and understand biomarkers within your target populations at every stage of research and clinical development – from assay development and validation to clinical trial support.
High quality IHC services fit for any stage of research and development
Preclinical and Translational Studies
We apply expert knowledge of fundamental biological processes to understand targets in preclinical models and accelerate transition to the next stage of development
Our experts start with the end in mind to tailor assays for the right targets in the right patients on the right platforms
Expert determination and optimization of assay performance
Unique integrated biospecimen and expert multi-omic services - flow cytometry, ELISA, sequencing and IHC - enable a thorough understanding of target expression.
Clinical Trial Services
Get high quality results at speed and scale to accelerate global clinical trials using a single chain of custody that adheres to all appropriate regulations and quality standards
Leverage the expertise behind one of the most successful companion diagnostic on the market to advance your companion diagnostic programs
Pathology Biomarker Training Services
Accelerate adoption postmarket with expert training for pathologists and technicians
Leverage Discovery’s expert cell-based services to conduct targeted immunophenotyping, functional and other cell-based studies and analyses.
Need biospecimens to build your study cohorts?
Discovery is a global market leader in biospecimen analysis, procurement, and distribution for pharmaceutical, biotechnology, and diagnostics industries.
Discovery offers a full spectrum of biospecimen solutions for diseased patients and healthy donors. From small and simple projects to complex prospective studies, Discovery has the expertise, inventory and global clinical networks to meet your biospecimen needs.
Contact Us Today
to propel your projects with The Power of Discovery.™